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Objectives: To compare the costs of endovascular neurysm treatment versus open surgery during the perioperative 
period. 
Methods: Retrospective analysis of a consecutive s ries of 44 patients undergoing infrarenal abdominal neurysm repair 
from February 1995 to March 1996 at a university teaching hospital. 
Results: No endovascular procedure was converted toopen repair. Operative time was shorter for endovascular treatment 
(207.6 min vs. 229.1 rain, n.s.), as well as postoperative intensive care unit stay (ICU, 22.7 h vs. 55.0 h, p = 0.017) and 
the postoperative r covery period (5.6 days vs. 13.3 days, p<O.O01). Open surgery generated significantly more costs 
(25 374.07 ECU vs. 22 268.78 ECU, p<O.O01), despite valuation and a more expensive endovascular procedure (10 699.48 
ECU vs. 4032.01 ECU, p<O.O01). During the study, costs for open surgery exceeded the cost for endovascular treatment 
by 13.95%. 
Conclusions: Endovascular neurysm treatment is cost effective and less expensive than open surgery. The main reason 
for cost saving is faster patient recovery after surgery, associated with a shorter LOS in the patients treated with 
endovascular p ocedure. 
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Introduction 
Because the natural history of untreated abdominal 
aneurysms leads to a 5-year survival rate of less than 
20% 1 as compared to 64% after surgical repair in 
contemporary series, 2'3 surgery is regarded as the 
method of choice for the treatment of this condition. 
Elective abdominal neurysm surgery through an open 
approach is safe with regard to mortality rates and 
long-term outcome after the procedure. 2 The procedure 
is regarded as cost effective when applied to most 
patients presenting with aneurysms of 5 cm in dia- 
meter or more. Age might be a factor of special con- 
sideration when surgery is applied to octogenarians, 
but it is of general acceptance that surgery should not 
be denied in these cases when there are no precluding 
risk factors present. 2"44 Surgery might also be cost 
effective for smaller aneurysms, 7 but this seems to 
be dependent on local factors, such as cost for the 
* Address correspondence to: Th. HOlzenbein, AKH, Department 
of Surgery, Wahringer GCtrtel 18-20, A-1090 Vienna, Austria. 
procedure and screening programs. The goal of elect- 
ive surgery is to prevent aneurysm rupture, which is 
not only affected with a high morbidity and mortality, 
but is also associated with extremely high costs .  4'6'8 
Endovascular abdominal aneurysm treatment has 
been developed recently, 9 and it is being applied with 
increasing enthusiasm. However, there are difficulties: 
not every patient may be a suitable candidate for this 
method, and a variety of additional screening tests 
are needed to obtain the information ecessary for 
successful graft implantation. There is additional 
need for specially designed OR facilities equipped 
with technology comparable to an angiography suite. 
Finally, a variety of implants, either self-made or 
commercially manufactured, are currently under in- 
vestigation. These are all more expensive than stand- 
ard vascular grafts. 
Economic aspects are playing art increasingly im- 
portant role in modern medical management. Newly 
introduced methods will not only be evaluated for 
their safety and efficacy, but also for their cost ef- 
fectiveness. Is the new approach a true medical pro- 
gress - less invasive surgery for a group of patients, 
1078-5884/97/100265 + 08 $12.00/0 © 1997 W.B. Saunders Company Ltd. 
266 Th. J. HSIzenbein et aL 
which is known to be at a high risk for surgery? Or 
is it a matter of prestige, to offer a highly advanced 
and technically challenging procedure to a group of 
carefully selected patients? Will the decisions for mini- 
mally invasive procedures in the aorta be driven by 
patient preference, 1° and may vascular surgeons be 
forced into an expensive procedure with an un- 
predictable outcome? 
To address these questions, a comparative valu- 
ation within a small group of patients undergoing 
elective aneurysm treatment either through open sur- 
gery or the new endovascular pproach was under- 
taken. The setting was an academic teaching hospital, 
and the costs of these procedures were evaluated with 
regard to efficacy and outcome. 
Methods 
Inclusion criteria 
A consecutive s ries of patients who underwent elect- 
ive surgical treatment of an infrarenal AAA from 
February 1995 to March 1996 was analysed for the 
purpose of this study. The time frame was selected 
because the endovascular graft was available to the 
department from February 1995. Patients were con- 
sidered to be suitable candidates, except for the fol- 
lowing: complex aneurysms (i.e. open surgery for 
inflammatory aneurysms and extension to or above the 
main renal arteries and/or other suprarenal rteries), 
simultaneous main renal artery reconstruction, or re- 
vascularisation of the lower extremities during the 
same stay. All patients undergoing the endovascular 
procedure had to be fit to undergo open surgery as 
well. Data were collected retrospectively from the 
patient's charts, outpatient records and the hospital's 
computerised administration records. 
Operative and postoperative procedures 
Open procedures were carried out through a midline 
abdominal incision, with vascular control beneath the 
renal arteries in all cases. The vascular graft used was 
left to the surgeon's preference. All patients received 
general anesthesia with the routine use of a cell-saving 
device. For all endovascular procedures a modular 
endovascular graft system (Stentor®, Mintec: Free- 
town, Bahamas) was used. The access ite was most 
commonly the femoral artery, but the external iliac 
artery was used if the femoral artery was too small to 
accommodate he large bore sheath, or if there was 
severe kinking of the iliac arteries. In addition to the 
graft system avariety of guide wires, balloon catheters 
and other endovascular devices were used, depending 
on the progress of the procedure. All patients received 
general anesthesia. 
Patients undergoing the endovascular pproach ex- 
pressed their informed consent o the experimental 
nature of the procedure, and the program was con- 
ducted under the supervision of the institutional ethics 
committee. The endovascular grafts were used and 
implanted according to the recommended guidelines 
of the ad hoc Endovascular Graft Committee of the 
SVS/ICVS. 1I 
ICU admission for at least 12h was used for all 
endovascular patients, according to the ethics com- 
mittee recommendation. This protocol was violated 
only once, because of an unexpected bed shortage. 
ICU admission was not routinely used for open surgery 
patients, who were admitted only if necessary. If a 
patient was not transferred tothe ICU postoperatively, 
the first 24 h were spent in an intermediate care facility. 
Cost calculation 
For the purpose of this study the costs, not the charges, 
were used. 12 The cost calculation was performed by 
the hospital's controlling and finance departments. 
The specific problems of reimbursement and financing 
of the Austrian health care system 13 were not in- 
vestigated in detail for the purpose of this study. A 
catalogue of costs was then created for all procedures, 
and this applied individually to each patient. 
The actual cost of i day of admission to the vascular 
surgery ward was determined by the hospital's con- 
trolling department. The amount computed included 
the costs for services provided by other departments 
in the hospital (e.g. radiology, laboratory, blood bank, 
pathology and anesthesia) nd labour costs (the ratio 
of patients: qualified nurses in the vascular surgery 
ward is 1:1.5, which is above average). 
OR costs were estimated by adding several variables: 
number of personnel necessary for the procedure 
(number of physicians, crub nurses, X-ray technicians 
and other support staff), time in OR, and the cost of 
running and maintenance of the general OR equip- 
ment, including the use of special equipment (fluoro- 
scopy equipment, autotransfusion, etc.) as well as costs 
for all expensive items such as implant(s), guide wires, 
catheters, and disposable items for the autotransfusion 
equipment. Less expensive items such as disposables, 
draping, suture material, skin staples, etc. were costed 
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Table 1. Demographic  data of the 44 patients undergoing either 
open aneurysm surgery (OAS, n = 22) or endovascular aneurysm 
treatment (EAT, n = 22). 
OAS EAT 
n=22 n=22 
Sex (M/F) 21/1 21/1 n.s. 
Mean age 69.5 (54.7-83.9) 70.1 (54.6-76.9) n.s. 
Mean height (cm) 172.5 (161-184) 174.1 (160-185) n.s. 
Mean weight (kg) 77.8 (50-109) 80.9 (52-110) n.s. 
Smoking history 15 (68.2%) 13 (59.1%) n.s. 
Diabetes 4 (18.2%) 3 (13.6%) n.s. 
Hypertension 13 (59.1%) 13 (59.1%) n.s. 
Dyslipidaemia 9 (40.9%) 7 (31.8%) n.s. 
Pulmonary disease 10 (45.5%) 14 (63.6%) n.s. 
Prev. laparotomies 8 (36.4%) 10 (45.5%) n.s. 
Cardiac disease 
(non-ischaemic) 8 (36.4%) 9 (40.9%) n.s. 
Ischaemic heart disease 9 (40.9%) 11 (50.0%) n.s. 
Previous CABG 1 (4.5%) 2 (9.1%) n.s. 
Previous vascular surgery 3 (13.6%) 2 (9.1%) n.s. 
CABG = coronary artery bypass grafting. 
for five procedures (two open tube grafts, two open 
bifurcated grafts and one endovascular procedure), 
and then averaged. 
Additional costs due to admission for special care, 
such as ICU or recovery room, were estimated in the 
same way as the costs for the general vascular surgery 
ward. Recovery room costs were about one and a half 
times the general ward costs due to an increased 
amount of nursing staff (ratio patients: qualified nurses 
was 1:3), physicians and other support ing personnel. 
The running costs of the ICU were divided by the 
number  of hours of patient occupation in the respective 
time period, giving an estimate of the costs of an 
average of i h of admission to this ICU. The ratio of 
nurses per patient in ICU was 3.6:1. This ensures a 
24 h 1:1 ratio between nurses and patients. 
All expenses are given in European Currency Units 
(ECU) calculated with the exchange rate to the Aus- 
trian Schilling dated to April 30, 1996 (100 ECU= 
1322.50 6S). 
Results 
Forty-four patients met the inclusion criteria during the 
study period. Twenty-two underwent open aneurysm 
surgery (OAS), and 22 endovascular aneurysm treat- 
ment (EAT). The two groups were comparable with 
regard to age, sex, and general risk factors for vascular 
disease (Table 1). Cardiac and pulmonary risk factors 
were equally balanced. There was no major difference 
in the number  of previous laparotomies, as well as 
cardiac or other vascular procedures (Table 1). Anaes- 
thesic risk was calculated for both groups according 
Table 2. Aneurysm morpho logy  and anatomical properties in the 
44 patients undergoing either open aneurysm surgery (OAS, n = 
22) or endovascular aneurysm treatment (EAT, n = 22). 
OAS EAT 
n=22 n =22 
Max. aneurysm diameter (cm) 5.57 5.34 n.s. 
Distance to renal artery (ram) 21.7 25.7 n.s. 
Accessory renal artery* 4 3 n.s. 
Inferior mesenteric artery patentt 6 7 n.s. 
Hypogastric arteries occluded 5 3 n.s. 
Hypogastric arteries aneurysmatic 3 2 n.s. 
* See text. 
t See text. 
n.s. = not significant. 
to the ASA-score, 14 and no statistically significant dif- 
ference between OAS (ASA II: 0; ASA III: 9; ASA IV: 
13) and EAT (ASA II: 0; ASA III: 8; ASA W: 14) 
could be demonstrated. The average diameter of the 
aneurysm was slightly larger in the OAS group than 
in the EAT group, but the difference was not significant 
(Table 2). Other morphological parameters uch as 
length of the proximal cuff, accessory renal arteries, 
patent inferior mesenteric artery (IMA), or involve- 
ment of the hypogastric artery did not differ sig- 
nificantly between the groups (Table 2). 
The overall operative time was slightly shorter for 
EAT procedures as compared to OAS, but the dif- 
ference was not significant (Table 3). However,  
endovascular implantation of tube grafts required sig- 
nificantly less time than open surgery for tube grafts 
(OAS: 246.7 min, EAT: 167.1 rain, difference: p=0.024, 
Student's t-test). In contrast, bifurcated grafts required 
more operative time in the endovascular group as 
compared to the open implantation of a bifurcated 
graft (OAS: 185m in; EAT: 241min, difference: p= 
0.017, Student's t-test). A different approach was 
undertaken in the management  of accessory renal 
arteries and in the case of a patent IMA. Accessory 
renal arteries were left in the circulation in OAS- 
patients (n = 4) by tailoring the proximal aortic cuff to 
accommodate the artery origin. In the EAT patient 
accessory renal arteries were occluded intentionally in 
Table 3. Operative data for the 44 patients undergoing either 
open aneurysm surgery (OAS, n = 22) or endovascular aneurysm 
treatment (EAT, n = 22). 
OP duration Bifurcated/ Blood 30-day 
median tube grafts units* mortality* 
(range) n/n (average) n (%) 
OAS 229.1 (105-340) 6/16 2.173 3 (13.6%) 
EAT 207.6 (115-570) 12/10 0.55 0 (0%) 
p=n.s, p=n.s, p-0.009 p=n.s. 
* See text. 
n.s. =not significant. 
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Table 4. Admission to hospital and duration of intensive care unit (ICU) stay in the 44 patients undergoing either open aneurysm 
surgery (OAS, n = 22) or endovascular aneurysm treatment (EAT, n = 22). 
Evaluation Surgery Total 
Pre-surg. adm Preop LOS ICU stay Postop LOS Adm for surg. Total adm 
(days) (days) (h) (days) (days) (days) 
OAS 3.0 (0-14) 5.6 (1-30) 55.0 (0-216) 13.3 (5-41) 19.8 (8-45) 22.8 (13-45) 
EAT 7.2 (0-10) 1.6 (1-11) 22.7 (0-69) 5.6 (3-16) 8.1 (4-18) 14.9 (9-26) 
p = 0.017 p<0.001 p<0.001 p<0.001 
Adm = Admission to hospital; LOS = length of stay; Preop = preoperative; Postop = postoperative; Pre-surg. adm = admission separate from 
admission for surgery, designated for evaluation only. 
two cases - leading to an estimated reduction of renal 
blood flow of <30%, but otherwise left in circulation 
(Table 2). All patent IMA's were occluded within the 
EAT-procedure, while three IMA's were reimplanted 
during OAS. 
Blood requirement was significantly ess in the EAT 
group compared to the OAS group. Seventeen patients 
required no transfusion atall. Nine patients in the OAS 
group required additional blood for autotransfusion. 
During the procedure an average of 0.23 units were 
transfused for EAT vs. 1.21 units for OAS (difference: 
p = 0.0262, Student's t-test). The total number of blood 
units transfused was 0.55 units in the EAT group 
compared to 2.73 units in the OAS group (difference: 
p=0.009, Student's t-test). Two-thirds of the blood 
transfused in EAT procedures was used for only two 
patients. One patient underwent the procedure under 
coumadin therapy after combined CABG and aortic 
valve replacement, and this caused the severe leaking 
through the haemostatic valves of the sheaths and the 
graft delivering catheter during the procedure. The 
other patient presented with a thrombosed graft 
limb postoperatively and underwent successful trans- 
brachial thrombolysis on the second postoperative day, 
complicated by bleeding from the open access ite in 
the groin, requiring surgical haematoma evacuation. 
Postoperative ICU stay was significantly onger for 
patients undergoing OAS, as compared to EAT (22.7 h 
vs. 55.0 h; p = 0.017, Table 4), despite a different policy 
to ICU admission in the two groups. In general, EAT 
patients transferred tothe ICU required no ventilatory 
support. However, the reason for admission to the 
ICU was the ethics committee recommendation to 
offer these patients pecial surveillance in an ICU for 
at least 12 h. Discharge from the ICU was usually the 
morning after surgery. Fifteen of the 22 OAS patients 
(68%) were admitted to the ICU. In one-third this was 
for an overnight stay; the others pent a variable time 
between 3 and 9 days because of prolonged ventilatory 
and circulatory support. 
The average duration of admission was 14.9 days 
in the EAT group and 22.8 in the OAS group, including 
evaluation time for stent grafting, as well as the ad- 
mission period for the surgical procedure (Table 4). 
Presurgical testing was performed in a separate ad- 
mission in all but one of the EAT patients. Hospital 
discharge during the time necessary for manufacturing 
the endovascular g aft was 6 weeks on average. Seven 
of the 22 OAS patients in whom the endovascular 
management was abandoned due to anatomical 
reasons were also admitted twice. The average time 
for this admission was 7.2 days in the EAT group and 
3.0 days in the entire OAS group. Most of the EAT 
patients were then admitted the day before surgery 
as soon as their grafts were ready for implantation. In
the OAS patients preoperative testing was usually 
performed within the same stay, unless they had been 
evaluated for a possible ndovascular pproach. This 
required an average of 5.6 days before surgery. There- 
fore the average time of admission to complete all 
tests before surgery was comparable both in patient 
groups (EAT 8.4 days vs. OAS 8.6 days). The post- 
operative LOS was significantly shorter in the EAT 
group compared to the OAS group (5.6 vs. 13.3 days, 
difference: p =0.001, Student's t-test). In addition, all 
EAT patients were discharged home, whereas ome of 
the OAS patients were transferred to other hospitals 
for further ecovery or other secondary care facilities. 
No patient died in the EAT group within the hospital 
or within the first 30 days following the procedure. In 
the OAS group one patient died within the hospital 
stay on day four after surgery due to myocardial 
infarction. A further two patients died within 30 days 
after discharge from hospital (myocardial infarction 
in both patients on day 16 and 28 after surgery, 30- 
day mortality: 13.6%). The difference between the 
groups does not reach statistical significance (p = 0.26, 
two tailed Fisher's exact est). No more patient deaths 
were observed in either group after a median follow- 
up of 9 months in the EAT group and 7.1 months in 
the OAS group. 
The costs for the entire procedure are summarised 
in Fig. 1. The three biggest factors were LOS, duration 
of stay at the ICU facility and the operative procedure. 
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Fig. 1. Comparison ofcosts between open aneurysm surgery (OAS) 
and endovascular neurysm treatment (EAT). Costs for OR, ICU 
and admission tohospital are absolute numbers, given in European 
Currency units (ECU). Specific osts (e.g. laboratory costs, X-ray, 
etc.) are broken up separately. (77) EAT; (11) OAS. (*) Difference 
statistically significant (p<0.001, Student's t-test). 
These factors account for 80% of the entire costs. The 
costs for the operative procedure itself were more 
expensive for EAT than for OAS (EAT 10 699.48 ECU 
vs. OAS 4032.09 ECU, p<0.001, Student's t-test). The 
difference was due to the expense for the endovascular 
graft(s) and the additional endovascular instrumenta- 
tion (guide wires, balloon catheters, pecial task cath- 
eters). The calculation for the OR costs is shown in 
Fig. 2. The costs for ICU stay were higher for OAS 
compared to EAT (OAS 4933.82 ECU vs. EAT 2036.33 
ECU, p<0.001, Student's t-test). The additional ad- 
mission for stent graft evaluation was also more ex- 
pensive for EAT compared to OAS, but this is of 
less influence as both groups spent the same time in 
hospital until the operative procedure was performed. 
The difference in LOS is entirely due to the longer 
postoperative LOS in OAS patients. The costs for 
admission were 9532.97 ECU for EAT and 16408.24 
ECU for OAS. The difference was statistically sig- 
nificant (p<0.001, Student's t-test). All additional cost 
factors were of minor importance when compared to 
the factors above. The additional cost of the evaluation 
tests (graded angiography, spiral contrast computed 
tomography (CT)) the cost for intraoperative angio- 
graphy and the postoperative completion tests (i.v. 
DSA, spiral contrast CT) made up for only 9.8% of the 
entire costs for EAT. The total average cost for an 
EAT procedure was 22 268.78 ECU, as compared to 
25 374.07 ECU for OAS. 
Discussion 
In this study a retrospective cost comparison was 
undertaken in a small series of patients undergoing 
elective infrarenal aneurysm anagement by two dif- 
ferent methods. Despite the fact that this study was not 
prospectively randomised, the two groups of patients 
were comparable with regard to their initial health 
status, risk factors for vascular disease and comor- 
bidities as well as their anatomical aneurysm prop- 
erties. There was no difference in the duration of the 
procedure, but the open procedure required sig- 
nificantly more blood than the endovascular pproach, 
despite the use of a cell saving device. Postoperative 
ICU stay was significantly longer in the OAS group 
compared to the EAT group, despite a different policy 
for admission to the ICU facility. Admission to hospital 
was significantly longer for OAS as compared to EAT. 
As the time for evaluation before surgery was the 
same in both groups, this is entirely due to the period 
of postoperative r covery. There was no statistically 
significant difference in outcome of surgery, although 
there was no early mortality in the EAT group com- 
pared to the OAS group. There was one early graft 
occlusion in the endovascular graft group, but this 
was successfully reopened by thrombolytic therapy. 
Converting an endovascular procedure to open repair 
can be difficult and is associated with a high morbidity 
and mortality. 15During the study period no endo- 
vascular procedure had to be converted and no severe 
procedure-related complication was observed in either 
group. It is difficult to estimate how a single failed 
endovascular procedure or one major complication i  
the open surgical group would have changed the cost 
calculation because of the uncertain outcome. 
Postoperative outcome was similar in both groups. 
The mortality of elective aneurysm surgery at our 
department was 3%, and has been previously re- 
ported. 3There has been no change in policy since then, 
and the rate is within the range reported in literature. 2 
During the study period there were three deaths within 
the 44 patients (overall mortality 6.8%), and all deaths 
were confined to the open surgical group. Never- 
theless, there is no convincing evidence that patients 
undergoing either procedure were at less risk for 
surgery. As part of our protocol EAT patients were 
required to be fit for open surgery as well. It may be 
speculated that open surgery is more of an insult 
than endovascular t eatment, but our study failed to 
demonstrate this. ICU admission was not necessary 
in any of the EAT patients for medical reasons. In 
contrast, all patients who were admitted to the ICU 
after open surgery were unstable, and most required 
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EAT 
Labour  costs 
Physicians (surgery) 
Physicians (radiology) 
OR nurses 
Radiology technicians 
OR technician 
Other OR-Personnel 
Summary of labour 
Costs/min 
0.97 
0.97 
0.45 
0.41 
0.41 
0.29 
N Minutes Cost 
Ordering # 
Medical article requirements 
Draping, gowns 
Sterile draping, thoracic set 30053486 
Sterile genital draping 30041481 
Table covering 80 x 150 30004870 
Sterile gown large (set of 4) 30041447 
Sterile gown small (1) 30041441 
B arriere sheat, large 30041456 
Barriere sheat, small 30041479 
Sterile basine cover 30064662 
Pouch, 707030, s,augert 30004850 
Steri-Drape 1050 19364 
Gloves, sempermed 30042051 
Suction, drainage 
Suction set (704906527) 
Suction drain set, Vygon 
Cost/unit 
Robinson suction set CH30 30008197 
Tubing set Dideco BT 740 30003014 
Tubing set Dideco BT 710 30003011 
29.45 
2.17 
1.18 
15.05 
4.32 
5.79 
3.36 
1.89 
1.06 
4.98 
0.37 
30002930 2.30 
30002930 1.19 
18.50 
85.48 
67.52 
Blades, suturing 
Scalpel blade #20 30003223 0.07 
Scalpel blade #15 30003221 0.07 
Scalpel blade # 11 30003219 0.07 
Scalpel blade #10 30003218 0.07 
Vessel oops maxi, red 30023359 1.11 
Vessel oops mini, blue 30023360 1.11 
Dexon II 3/0 40665.1 44220 8.16 
Dexon II 2/0 406660 53409 8.56 
Vicryl V 964 H 23347 28.10 
Vicryl V 316 H 18529 14.82 
Vicryl V 908 E 19696 65.44 
Prolene 8556 H 21682 20.09 
Prolene 8521 H 19968 20.09 
Prolene 8522 H 25251 20.09 
Prolene 8557 H 22524 35.21 
PH-silk EH 7633 SH 18542 13.03 
PH-silk EH 6717 SH 17523 8.09 
Skin staples Multifire 59025 30070319 30.89 
Cautery tip cleaner 30003254 0.83 
2 414 401.01 
2 414 401.01 
2 414 185.95 
1 165 68.25 
1 207 84.52 
2 40 11.80 
1152.53 
N Cost 
1 29.45 
1 2.17 
1 1.18 
1 15.05 
1 4.32 
1 5.79 
1 3.36 
1 1.89 
2 2.12 
1 4.98 
10 3.67 
1 2.30 
1 1.19 
1 0.07 
1 0.07 
1 0.07 
1 0.07 
1 1.11 
1 1.11 
1 8.16 
1 14.82 
2 40.18 
1 13.03 
1 30.89 
1 0.83 
OAS 
N Minutes Cost 
3 687 665.44 
2 458 205.71 
1 229 93.50 
2 40 11.80 
976.45 
N Cost 
1 29.45 
1 1.18 
1 15.05 
1 4.32 
1 1.89 
2 2.12 
1 4.98 
10 3.67 
1 2.30 
1 18.50 
1 85.48 
1 67.52 
1 0.07 
1 0.07 
1 0.07 
1 0.07 
1 1.11 
1 1.11 
1 8.56 
1 28.10 
1 14.82 
2 70.88 
3 60.27 
1 20.09 
3 105.63 
1 8.09 
1 30.89 
1 0.83 
Fig. 2. Actual OR cost calculation for open aneurysm surgery (OAS) and endovascular aneurysm treatment (EAT) procedures as 
performed by the departments of controlling and finance. Cost expression is performed in European Currency units (ECU). 
p ro longed vent i la to ry  and  c i rcu la tory  suppor t .  The  
t ime of ICU admiss ion  is comparab le  to repor ts  in 
l i te ra ture /  
LOS for the  EAT procedure  has  been  repor ted  be-  
tween 3.8 days  16 and  7 days /7  and  for e lect ive  OAS 
between 12.7 days  and  14 days  in the U.S.A. ,  4'6 where  
most  of the eva luat ion  is per fo rmed in outpat ient  
cl inics. In  our  set t ing  the  preoperat ive  eva luat ion  ac- 
counted  for 8 days  of the ent i re  LOS,  rang ing  f rom 1 
to 30 days.  Due  to the Aust r ian  re imbursement  po l i cy  
we  are encouraged to per fo rm the ent i re  p reoperat ive  
eva luat ion  on  an inpat ient  basis. There fore  on ly  the 
postoperat ive  LOS can be compared  to LOS repor ted  
in l i terature,  wh ich  is w i th in  the  range  repor ted / In  
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EAT 
Ordering # Cost/unit 
Sponges, dressing, miscellaneous 
Injection cannula 20G x 2 30001709 0.02 
Syringe 20 mi 30001692 0.08 
BDL 4354229 Port-a-Cul 28574 2.50 
Normal saline 1000 ml 12086 1.86 
Heparin-IMM 1000IU/ml 11171 1.42 
Primapore 18/8.25 cm 13130 0.70 
Primapore 25/8.25 cm 13131 0.87 
Sterile cotton swab K2 13207 0.06 
Sponges 18x 8 cm 8× 13324 0.08 
Sponges, Setpack San 1809 17471 0.39 
Sponges, Setpack ZR3M10 16046 1.84 
Sponges, peanut size 2 35611 1.90 
Abdominal corselette 30020765 10.96 
Tabotamp 10 x 20 cm 12564 15.86 
Guidewires, catheters, grafts 
Introd. set RFSB-901101 30031427 21.17 
GWSchn. TM 35-150-36 30008271 13.61 
GW Terumo Rfpa 35183 30022342 34.03 
GW Schn. 30601, 0.035" 30022227 163.33 
Angiography cath. 523852 30044083 24.20 
Angiography cath. 521764 30026141 24.20 
Dilat. cath. BMX 12-252 30047986 211.72 
Dilat. cath. BMX 12-156 30031419 294.14 
Aortic graft (average) 689.60 
Stented endograft (average) 4499.05 
X-ray material 
Angiography roll San 1939 17802 2.49 
Optiray 320mg/ml, 200 ml 38929 134.14 
X-ray film LTZBL 14.17 30013623 2.70 
Summary of medical articles 
N Cost 
4 0.08 
4 0.32 
3 7.50 
2 3.72 
1 1.42 
1 0.70 
1 0.87 
2 0.12 
10 0.80 
10 3.90 
1 15,8~ 
2 42.34 
1 13.61 
1 34.03 
1 163.33 
1 24.20 
1 24.20 
1 211.72 
1 294.60 
1 4499.05 
1 2.49 
1 134.14 
6 16.22 
Instal lation costs 
Purchase cost Utilisation time 
(years) 
Surgical suction unit, mobile 1930.28 
OR light 2004 Duo and satellite 2004 14412.10 
OR light 2004 Duo and satellite 2007 13888.24 
OR-Table, stationary 33707.52 
Pat. wanning unit, Bair Hugger 500 2495.20 
Cautery, Radiotom Siemens 6441.13 
X-ray image amplifier system 95841.36 
X-ray printer Agfa Gaevert Laser 88291.64 
10 
8 
10 
8 
5 
10 
10 
6 
Summary of installation costs 
Baseline cost of the procedure 
52.28% "Gemeinkostenzuschlag" (= overheads) 
Cost of the procedure 
5683.67 
Cosffproc 
1.28 
10.52 
9.21 
24.60 
2.32 
4.27 
65.10 
74.20 
189.99 
7026.19 
3673.29 
10699.48 
N 
1 
3 
1 
1 
1 
2 
10 
10 
10 
10 
1 
1 
Fig. 2. Contd 
OAS 
Cost 
0.02 
0.24 
1.42 
0.70 
0.87 
0.12 
0.80 
3.90 
18.40 
19.00 
10.96 
15.86 
689.60 
16.22 
1461.18 
Cost/proc 
1.42 
11.64 
10.19 
27.21 
2.56 
4.73 
70.34 
82.08 
210.18 
2647.81 
1384.20 
4.032.01 
add i t ion  to that,  al l  EAT pat ients  were  d i scharged  
home,  whereas  some of the OAS pat ients  were  t rans-  
fe r red  to o ther  hosp i ta l s  for  fu r ther  recovery  or o ther  
secondary  care faci l it ies. We cou ld  ach ieve  fu r ther  cost  
cut t ing  by  per fo rming  the  preoperat ive  eva luat ion  in 
outpat ients  and  not  rout ine ly  us ing  ICU.  
The s tudy  repor ted  has severa l  l imi tat ions .  The  cost  
ana lys is  does  not  d i s t ingu ish  whether  the  pat ient  was  
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referred by a general practitioner, for complete valu- 
ation, or whether the patient had already been evalu- 
ated in another hospital. In addition there was no 
attempt o compare the cost of rehabilitation after 
discharge. While all of the endovascular patients were 
discharged home, many of the OAS patients were 
discharged to a hospital for further rehabilitation or 
to a secondary care facility. Neither did the study 
include the costs for follow-up or any further ad- 
missions to hospital for procedure-related reasons. It 
is current practice for all patients who undergo an 
open procedure to receive a physical exam, duplex 
examination of the graft and a blood test every 6 
months. All EAT patients also underwent i.v. DSA, 
and a spiral contrast CT at 3, 6 and 12 months post- 
operatively as part of the follow-up protocol. If a leak 
was detected further testing was undertaken and every 
attempt was made to seal the leak, which necessitated 
further hospitalisation costs. Procedure-specific com- 
plications uch as leakage should be calculated on an 
intermediate o long-term basis. However, long-term 
cost calculations are difficult to estimate because ad- 
ditional cost factors uch as rehabilitation, secondary 
care and survival may play an important role. With 
our small number of patients and the short period of 
follow-up, the outcome of such a complex investigation 
is speculative. 
In conclusion, our study shows that costs for an- 
eurysm repair are influenced by three major factors: 
admission to hospital, ICU stay and cost of the surgery. 
The procedural costs for EAT are almost hree times 
the cost for open surgery, and the cost of additional 
X-ray testing is five times as high in open surgery. But 
these costs are easily recouped by the shorter stay in 
the ICU and quicker postoperative r covery. 
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